Spirometric and radiological evaluation of the remnant lung long after major pulmonary resection: can compensatory phenomena be recognized in clinical cases?
大肺切除术后残肺的肺量测定和放射学评估:在临床病例中能否识别代偿现象?
基本信息
- 批准号:23592054
- 负责人:
- 金额:$ 3.33万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2011
- 资助国家:日本
- 起止时间:2011 至 2013
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
It has been generally accepted that lungs cannot regenerate in mature human. After a major lung resection, however, mechanical stretch, shear stress, and a variety of growth factors are induced in the remnant lung, and those are known to be driving forces for compensatory lung growth in animal models. Radiologically estimated "Lung Weight" is focused on as a significant parameter to determine severity of ARDS that is calculated by lung volume and density. Therefore, we also utilized the concept of radiologic estimation of lung weight for evaluation of the compensation. Before clinical investigation, a rational of radiologic lung weight was validated in healthy volunteers. This result met our hypothesis that radiologic lung weight is constant at any respiratory phase. Hypertrophic change of the remnant lung was recognized in living lung donors and lung cancer patients who underwent more than a 10-subsegment resection.
人们普遍认为,成年人的肺是不能再生的。然而,在大肺切除后,残余肺会受到机械拉伸、剪切应力和多种生长因子的诱导,而这些已知是动物模型中代偿性肺生长的驱动力。放射学估计的“肺重”是确定ARDS严重程度的重要参数,由肺体积和密度计算。因此,我们也利用肺重量的放射学估计的概念来评估代偿。在临床研究之前,在健康志愿者中验证了放射学肺重量的合理性。这一结果符合我们的假设,即放射学肺重量在任何呼吸期都是恒定的。残肺的肥厚变化在活肺供者和接受超过10亚段切除的肺癌患者中被识别出来。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MIZOBUCHI TERUAKI其他文献
MIZOBUCHI TERUAKI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Examination of prediction and promotion factors of compensatory lung growth ~focus on bFGF~
肺代偿性生长的预测和促进因素探讨~关注bFGF~
- 批准号:
19K18227 - 财政年份:2019
- 资助金额:
$ 3.33万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Structural Plasticity in Compensatory Lung Growth and Remodeling
代偿性肺生长和重塑中的结构可塑性
- 批准号:
9263555 - 财政年份:2017
- 资助金额:
$ 3.33万 - 项目类别:
Mechanisms of enhanced tumor growth during compensatory lung growth after major lung resection
大肺切除术后代偿性肺生长过程中肿瘤生长增强的机制
- 批准号:
15K10259 - 财政年份:2015
- 资助金额:
$ 3.33万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
マウス代償性肺成長におけるNotch/TTF-1シグナルの幹細胞ニッチへの関与
Notch/TTF-1信号参与小鼠代偿性肺生长干细胞生态位
- 批准号:
26861128 - 财政年份:2014
- 资助金额:
$ 3.33万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
The examination of compensatory lung growth utilizing transgenic mice
利用转基因小鼠检查代偿性肺生长
- 批准号:
25893034 - 财政年份:2013
- 资助金额:
$ 3.33万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Nanoparticle Drug Delivery in Post-Pneumonectomy Compensatory Lung Growth
纳米颗粒药物输送在肺切除术后代偿性肺生长中的应用
- 批准号:
8403836 - 财政年份:2012
- 资助金额:
$ 3.33万 - 项目类别:
Nanoparticle Drug Delivery in Post-Pneumonectomy Compensatory Lung Growth
纳米颗粒药物输送在肺切除术后代偿性肺生长中的应用
- 批准号:
8601880 - 财政年份:2012
- 资助金额:
$ 3.33万 - 项目类别:
Nanoparticle Drug Delivery in Post-Pneumonectomy Compensatory Lung Growth
纳米颗粒药物输送在肺切除术后代偿性肺生长中的应用
- 批准号:
8978321 - 财政年份:2012
- 资助金额:
$ 3.33万 - 项目类别:
Nanoparticle Drug Delivery in Post-Pneumonectomy Compensatory Lung Growth
纳米颗粒药物输送在肺切除术后代偿性肺生长中的应用
- 批准号:
8788836 - 财政年份:2012
- 资助金额:
$ 3.33万 - 项目类别:
Nanoparticle Drug Delivery in Post-Pneumonectomy Compensatory Lung Growth
纳米颗粒药物输送在肺切除术后代偿性肺生长中的应用
- 批准号:
8225851 - 财政年份:2012
- 资助金额:
$ 3.33万 - 项目类别: